Literature DB >> 19901314

Undisclosed changes in outcomes in randomized controlled trials: an observational study.

Robert Ewart1, Harald Lausen, Norman Millian.   

Abstract

PURPOSE: We wanted to investigate the frequency of undisclosed changes in the outcomes of randomized controlled trials (RCTs) between trial registration and publication.
METHODS: Using a retrospective, nonrandom, cross-sectional study design, we investigated RCTs published in consecutive issues of 5 major medical journals during a 6-month period and their associated trials registry entries. Articles were excluded if they did not have an available trial registry entry, did not have analyzable outcomes, or were secondary publications. The primary outcome was the proportion of publications in which the primary outcome of the trial was, without disclosure, changed between that recorded in the trial registry and that reported in the final publication. The secondary outcome was the proportion of publications in which the secondary outcome was changed without disclosure.
RESULTS: We reviewed 158 reports of RCTs and included 110 in the analysis. In 34 (31%), a primary outcome had been changed, and in 77 (70%), a secondary outcome had been changed.
CONCLUSIONS: There are substantial and important undisclosed changes made to the outcomes of published RCTs between trial registration and publication. This finding has important implications for the interpretation of trial results. Disclosure and discussion of changes would improve transparency in the performance and reporting of trials.

Mesh:

Year:  2009        PMID: 19901314      PMCID: PMC2775624          DOI: 10.1370/afm.1017

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  17 in total

1.  Investigation of within-study selective reporting in clinical research: follow-up of applications submitted to a local research ethics committee.

Authors:  S Hahn; P R Williamson; J L Hutton
Journal:  J Eval Clin Pract       Date:  2002-08       Impact factor: 2.431

2.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

3.  Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.

Authors:  An-Wen Chan; Karmela Krleza-Jerić; Isabelle Schmid; Douglas G Altman
Journal:  CMAJ       Date:  2004-09-28       Impact factor: 8.262

4.  Chemotherapy with preoperative radiotherapy in rectal cancer.

Authors:  Jean-François Bosset; Laurence Collette; Gilles Calais; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Alain Daban; Etienne Bardet; Alexander Beny; Jean-Claude Ollier
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

5.  AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

Authors:  James B Bussel; David J Kuter; James N George; Robert McMillan; Louis M Aledort; George T Conklin; Alan E Lichtin; Roger M Lyons; Jorge Nieva; Jeffrey S Wasser; Israel Wiznitzer; Reggie Kelly; Chien-Feng Chen; Janet L Nichol
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

6.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Ann Intern Med       Date:  2007-10-16       Impact factor: 25.391

7.  False-positive results in clinical trials: multiple significance tests and the problem of unreported comparisons.

Authors:  I F Tannock
Journal:  J Natl Cancer Inst       Date:  1996-02-21       Impact factor: 13.506

8.  Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.

Authors:  Steven A Kaplan; Claus G Roehrborn; Eric S Rovner; Martin Carlsson; Tamara Bavendam; Zhonghong Guan
Journal:  JAMA       Date:  2006-11-15       Impact factor: 56.272

9.  International trial of the Edmonton protocol for islet transplantation.

Authors:  A M James Shapiro; Camillo Ricordi; Bernhard J Hering; Hugh Auchincloss; Robert Lindblad; R Paul Robertson; Antonio Secchi; Mathias D Brendel; Thierry Berney; Daniel C Brennan; Enrico Cagliero; Rodolfo Alejandro; Edmond A Ryan; Barbara DiMercurio; Philippe Morel; Kenneth S Polonsky; Jo-Anna Reems; Reinhard G Bretzel; Federico Bertuzzi; Tatiana Froud; Raja Kandaswamy; David E R Sutherland; George Eisenbarth; Miriam Segal; Jutta Preiksaitis; Gregory S Korbutt; Franca B Barton; Lisa Viviano; Vicki Seyfert-Margolis; Jeffrey Bluestone; Jonathan R T Lakey
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

10.  Return of chloroquine antimalarial efficacy in Malawi.

Authors:  Miriam K Laufer; Phillip C Thesing; Nicole D Eddington; Rhoda Masonga; Fraction K Dzinjalamala; Shannon L Takala; Terrie E Taylor; Christopher V Plowe
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

View more
  17 in total

1.  Drug research: marketing before evidence, sales before safety.

Authors:  David Klemperer
Journal:  Dtsch Arztebl Int       Date:  2010-04-23       Impact factor: 5.594

2.  Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications.

Authors:  Daniel M Hartung; Deborah A Zarin; Jeanne-Marie Guise; Marian McDonagh; Robin Paynter; Mark Helfand
Journal:  Ann Intern Med       Date:  2014-04-01       Impact factor: 25.391

3.  Comparison of protocols and registry entries to published reports for randomised controlled trials.

Authors:  Kerry Dwan; Douglas G Altman; Lynne Cresswell; Michaela Blundell; Carrol L Gamble; Paula R Williamson
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

4.  Protecting intellectual property associated with Canadian academic clinical trials--approaches and impact.

Authors:  Sue Ross; Laura Magee; Mark Walker; Stephen Wood
Journal:  Trials       Date:  2012-12-27       Impact factor: 2.279

5.  Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists.

Authors:  R M D Smyth; J J Kirkham; A Jacoby; D G Altman; C Gamble; P R Williamson
Journal:  BMJ       Date:  2011-01-06

6.  Outcome discrepancies and selective reporting: impacting the leading journals?

Authors:  Padhraig S Fleming; Despina Koletsi; Kerry Dwan; Nikolaos Pandis
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

7.  Selective Reporting of Outcomes in Tinnitus Trials: Comparison of Trial Registries With Corresponding Publications.

Authors:  Isabeau van Beurden; Megan J van de Beek; Jan A A van Heteren; Adriana L Smit; Inge Stegeman
Journal:  Front Neurol       Date:  2021-06-10       Impact factor: 4.003

8.  Use of trial register information during the peer review process.

Authors:  Sylvain Mathieu; An-Wen Chan; Philippe Ravaud
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

Review 9.  Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review.

Authors:  Kerry Dwan; Carrol Gamble; Paula R Williamson; Jamie J Kirkham
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

10.  Discrepancies between registration and publication of randomised controlled trials: an observational study.

Authors:  Kate F Walker; Graham Stevenson; James G Thornton
Journal:  JRSM Open       Date:  2014-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.